| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An association study of the neurotensin receptor gene with schizophrenia and clozapine response
|
Huezo-Diaz, P.
|
|
2004
|
66 |
2-3 |
p. 193-195
3 p.
|
artikel
|
| 2 |
Author index
|
|
|
2004
|
66 |
2-3 |
p. 205-206
2 p.
|
artikel
|
| 3 |
Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent
|
Heitmiller, Dwayne R.
|
|
2004
|
66 |
2-3 |
p. 137-142
6 p.
|
artikel
|
| 4 |
Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients
|
Mauri, Massimo C.
|
|
2004
|
66 |
2-3 |
p. 197-198
2 p.
|
artikel
|
| 5 |
Clozapine's effects on body weight and resting metabolic rate: a case series
|
Procyshyn, Ric M.
|
|
2004
|
66 |
2-3 |
p. 159-162
4 p.
|
artikel
|
| 6 |
Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
|
Heresco-Levy, Uriel
|
|
2004
|
66 |
2-3 |
p. 89-96
8 p.
|
artikel
|
| 7 |
Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study
|
Louzã, Mario R.
|
|
2004
|
66 |
2-3 |
p. 97-100
4 p.
|
artikel
|
| 8 |
Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample
|
Kavanagh, David J.
|
|
2004
|
66 |
2-3 |
p. 115-124
10 p.
|
artikel
|
| 9 |
Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression
|
Zink, Mathias
|
|
2004
|
66 |
2-3 |
p. 151-157
7 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2004
|
66 |
2-3 |
p. IFC-
1 p.
|
artikel
|
| 11 |
Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia
|
Buckley, Peter F.
|
|
2004
|
66 |
2-3 |
p. 143-150
8 p.
|
artikel
|
| 12 |
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
|
Green, Alan I
|
|
2004
|
66 |
2-3 |
p. 125-135
11 p.
|
artikel
|
| 13 |
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
|
Harvey, Philip D
|
|
2004
|
66 |
2-3 |
p. 101-113
13 p.
|
artikel
|
| 14 |
Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine
|
Littrell, Kimberly H
|
|
2004
|
66 |
2-3 |
p. 201-202
2 p.
|
artikel
|
| 15 |
Instructions to authors
|
|
|
2004
|
66 |
2-3 |
p. 203-204
2 p.
|
artikel
|
| 16 |
Keyword index
|
|
|
2004
|
66 |
2-3 |
p. 207-210
4 p.
|
artikel
|
| 17 |
Olanzapine-induced QTc prolongation in a patient with Wolff–Parkinson–White syndrome
|
Su, Kuan-Pin
|
|
2004
|
66 |
2-3 |
p. 191-192
2 p.
|
artikel
|
| 18 |
Secretin for refractory schizophrenia
|
Sheitman, Brian B.
|
|
2004
|
66 |
2-3 |
p. 177-181
5 p.
|
artikel
|
| 19 |
Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features
|
Alamy, Sayed S.
|
|
2004
|
66 |
2-3 |
p. 183-186
4 p.
|
artikel
|
| 20 |
Sex, ethnicity, and antipsychotic medication use in patients with psychosis
|
Arnold, Lesley M.
|
|
2004
|
66 |
2-3 |
p. 169-175
7 p.
|
artikel
|
| 21 |
Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications
|
Lasser, Robert A
|
|
2004
|
66 |
2-3 |
p. 163-167
5 p.
|
artikel
|
| 22 |
The effects of olanzapine on sensory gating in healthy participants
|
Carroll, Christine A.
|
|
2004
|
66 |
2-3 |
p. 187-189
3 p.
|
artikel
|
| 23 |
Treatment of tardive pharyngolaryngeal dystonia with olanzapine
|
Havaki-Kontaxaki, Beata J.
|
|
2004
|
66 |
2-3 |
p. 199-200
2 p.
|
artikel
|
Tijdschrift beschrijving